retatrutide phase 2 results obesity nejm 2023 in adults with over 104 weeks in the highest dose group had 30.3% weight loss. Nearly 2/3 reached BMI < 30 1 in 3 reached BMI < 25 Retatrutide TRIUMPH-1: Biggest Obesity Trial

The 5 mg formulation typically represents an intermediate titration dose used to evaluate patient response and minimize gastrointestinal side effects during dose escalation in clinical studies

Essentially, they make us less interested in eating and drastically reduce food cravings and preoccupation with food, leading to eating significantly less

If you have news tips, please send them to [email protected]

Good fat sources include avocado, olive oil, nuts and nut butters, fatty fish like salmon, and small amounts of cheese

The sustained reduction suggests ongoing hepatic benefits throughout treatment

What symptoms should I watch for and report